Samuli Ripatti
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (5)
Alcohol consumption is a major public health challenge, linked to substantial morbidity and mortality worldwide. Despite known genetic influences on alcohol use, relatively little is known about the genetic determinants of specific alcohol-related disease endpoints. In this study, we leveraged the extensive FinnGen study, comprising over 500,000 individuals with up to 56 years of follow-up, to investigate the genetic architecture of 19 alcohol-attributable disease endpoints and 41 disease endpoints in which alcohol is a known risk factor. We identified 93 fine-mapped genetic loci associated with 13 alcohol-attributable disease endpoints, including 37 loci not previously linked to alcohol use or alcohol-attributable disease endpoints. Genetic correlations were strong between mental and behavioural disorders due to alcohol, while alcohol-attributable organ injuries exhibited more distinct genetic profiles. Using a polygenic risk score (PRS) for alcohol use, we demonstrated significant risk stratification for several alcohol-related diseases. For example, individuals in the highest PRS decile showed markedly elevated risks not only for numerous alcohol-attributable diseases (HR = 1.50; 95% CI: [1.46–1.55], compared to the 10th–90th PRS percentiles), but also for opioid use (HR = 1.59; 95% CI: [1.38–1.83]), and to a lesser extent, for several other endpoints. These findings elucidate the complex genetic landscape of alcohol-related diseases, highlighting the potential utility of genetic risk profiling in clinical settings to identify individuals at heightened risk for alcohol-related health complications.
Year:
2025
BACKGROUND Digital communication of cardiovascular disease (CVD) risk directly to individuals can promote preventive actions. We have previously shown that communicating CVD-risk, including polygenic risk information through a web portal leads to about 20 % of individuals at high risk of CVD contacting a physician. OBJECTIVE To test if mobile-optimised risk communication combined with a chat-based digital clinic for consulting a physician would increase preventive actions among individuals at high risk of CVD. METHODS We studied N=4808 Finnish individuals, aged 40-60 years with no history of cardiovascular disease and at least one major risk factor for CVD. The digital clinic group (N=1050) received the intervention. Matched controls (N=3758) were sampled from our previous study, and they received CVD-risk information without chat-based access to health professionals. RESULTS Compared to the matched controls, individuals in the digital clinic group were more likely to seek contact with a physician following digital risk communication (36.4 % vs. 18.6 % of individuals at high risk sought contact; P=.03). Majority of participants found the risk communication and chat-based digital consultation easy to understand (95 %) and useful (93 %). CONCLUSIONS Mobile-optimised CVD-risk communication followed by an easy access to physician’s consultation considerably elevated the likelihood of contacting physician compared to only communicating the individual’s risk. Further research is needed to target the health care resources optimally in this mobile setting to the individuals most in need for risk-lowering actions.
Year:
2024
Background Sleep apnea is a common sleep disorder affecting at least ten percent of the population. It is caused by lack of breathing during sleep, typically mediated by obstruction of airways or less frequently by misdirected central signals for breathing. The primary risk factor is a high body mass index (BMI), causing airway obstruction. However, understanding risk factors for sleep apnea in non-obese (BMI 0.8), and single cell sequencing implicated HTR1F expression particularly in neurons. Analysis of eQTL data further supported a possible regulatory role in neurons (beta = -0.03, P = 1.2e-4). Finally, objectively measured sleep-activity data showed association with number awakenings during night (P = 5.6e-8). Conclusions The findings indicate association of HTR1F in sleep apnea particularly in the patient population within the non-obese BMI range and provide insight into the growing evidence of serotonin signaling as a factor modulating liability to sleep apnea.
Year:
2024
The high prevalence of autoimmune hypothyroidism (AIHT) - more than 5% in human populations - provides a unique opportunity to unlock the most complete picture to date of genetic loci that underlie systemic and organ-specific autoimmunity. Using a meta-analysis of 81,718 AIHT cases in FinnGen and the UK Biobank, we dissect associations along axes of thyroid dysfunction and autoimmunity. This largest-to-date scan of hypothyroidism identifies 418 independent associations (p 0.95) with the lead SNP at the locus, including low-frequency coding variants at LAG3 , ZAP70 , TG, TNFSF11, IRF3, S1PR4, HABP2, ZNF429 as well as established variants at ADCY7, IFIH1 and TYK2 . The variants at LAG3 (P67T), ZAP70 (T155M), and TG (Q655X) are highly enriched in Finland and functional experiments in T-cells demonstrate that the ZAP70 :T155M allele reduces T-cell activation. By employing a large-scale scan of non-thyroid autoimmunity and a published meta-analysis of TSH levels, we use a Bayesian classifier to dissect the associated loci into distinct groupings and from this estimate, a significant proportion are involved in systemic (i.e., general to multiple autoimmune conditions) autoimmunity (34%) and another subset in thyroid-specific dysfunction (17%). By comparing these association results further to other common disease endpoints, we identify a noteworthy overlap with skin cancer, with 10% of AIHT loci showing a consistent but opposite pattern of association where alleles that increase the risk of hypothyroidism have protective effects for skin cancer. The association results, including genes encoding checkpoint inhibitors and other genes affecting protein levels of PD1, bolster the causal role of natural variation in autoimmunity influencing cancer outcomes.
Year:
2024
Background Despite well‐recognized differences in the atherosclerotic cardiovascular disease risk between men and women, sex differences in risk factors and sex‐specific mechanisms in the pathophysiology of atherosclerotic cardiovascular disease remain poorly understood. Lipid metabolism plays a central role in the development of atherosclerotic cardiovascular disease. Understanding sex differences in lipids and their genetic determinants could provide mechanistic insights into sex differences in atherosclerotic cardiovascular disease and aid in precise risk assessment. Herein, we examined sex differences in plasma lipidome and heterogeneity in genetic influences on lipidome in men and women through sex‐stratified genome‐wide association analyses. Methods and Results We used data consisting of 179 lipid species measured by shotgun lipidomics in 7266 individuals from the Finnish GeneRISK cohort and sought for replication using independent data from 2045 participants. Significant sex differences in the levels of 141 lipid species were observed ( P <7.0×10 −4 ). Interestingly, 121 lipid species showed significant age‐sex interactions, with opposite age‐related changes in 39 lipid species. In general, most of the cholesteryl esters, ceramides, lysophospholipids, and glycerides were higher in 45‐ to 50‐year‐old men compared with women of same age, but the sex differences narrowed down or reversed with age. We did not observe any major differences in genetic effect in the sex‐stratified genome‐wide association analyses, which suggests that common genetic variants do not have a major role in sex differences in lipidome. Conclusions Our study provides a comprehensive view of sex differences in circulatory lipids pointing to potential sex differences in lipid metabolism and highlights the need for sex‐ and age‐specific prevention strategies.
Year:
2022
Collaborators (15)
Hanna Ollila
University of Helsinki
Matti Pirinen
University of Helsinki
Tuula Palotie
University of Helsinki
Nina Mars
University of Helsinki
Tiinamaija Tuomi
Professor
University of Helsinki
Aarno Palotie
University of Helsinki
Mykyta Artomov
Principal Investigator
Nationwide Children's Hospital
Kristina Hotakainen
University of Helsinki
Adel Bachour
University of Helsinki
Martin Broberg
University of Helsinki
Richa Saxena
Professor of Anaesthesia
Harvard Medical School
Pia Mäkelä
Research professor
Finnish Institute for Health and Welfare
Jaakko Kaprio
Research Director
University of Helsinki
Jukka Koskela
University of Helsinki
Jukka Partanen
Research Director, Professor
University of Helsinki
Make your next move.
Prepare your application
Review drafts before you send them.